A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

Open
USD3.18
High
USD3.21
Low
USD3.15
52 Week High
USD4.73
Monthly Return
-5.40%
Revenue
6M

Daily Vol.
17.72k
Avg. Daily Vol.
818.42k
Market Cap.
599M
52 Week Low
2.71
Annual Return
1.90%

Stock News

Centene’s Medicaid business and healthcare costs are a problem, and its stock plunges

Centene’s Medicaid business and healthcare costs are a problem, and its stock plunges

MarketWatch

Gen Z is grappling with global chaos—here's how they're coping with 'inheriting broken systems'

Gen Z is grappling with global chaos—here's how they're coping with 'inheriting broken systems'

CNBC

Unum America closes reinsurance transaction with Fortitude Re

Unum America closes reinsurance transaction with Fortitude Re

Yahoo

Lyft: Value Stock With Growth Dynamics

Lyft: Value Stock With Growth Dynamics

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.